• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Stasis Labs Lands $5M for Cloud-based Vitals Monitoring System

by Jasmine Pennic 11/16/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

stasis-labs

Stasis Labs, a Los Angeles, CA-based provider of cloud-powered vital monitoring system has raised $5M in seed financing led by RTP-HC, the healthcare-focused investment arm of RTP Ventures, with participation from Wonder Ventures, Techstars Ventures, and others. Founded in 2015, Dinesh Seemakurty got the idea for the startup after his grandfather was admitted to the hospital in India. His grandfather later prematurely passed away when doctors missed a deterioration in his vital signs due to a lack of adequate monitoring. “As a trained EMT, I knew the technology existed, and yet, hospitals weren’t buying it,” said Seemakurty.

Most hospital patients around the world are only seen by a nurse once every six hours. Due to the high cost and complexity of existing monitoring devices, these vulnerable patients are left alone without even a vitals monitor to watch over them. Tragically, up to 75% of injuries and deaths in hospitals happen to these vulnerable patients who lack basic medical supervision.

To resolve this, Stasis has built a cloud-connected vitals monitoring system that enables access to a fundamental medical tool around the world. The Stasis Monitor sits at the bedside and indicates the patient’s status through our unique iconic display. It is measured by six core vital signs:

– heart rate

– blood oxygen

– three-lead ECG

– respiratory rate

– blood pressure

– skin temperature

The Stasis System is currently live in multiple hospitals in Bangalore, India.

Green is good. Yellow is bad.

The monitor uses standard hospital probes to reach ICU-grade accuracy.

 “Stasis will be using the funds to continue expanding throughout Indian hospitals and prepare to enter the US and other markets worldwide,” said Maylahn. The patient monitoring market is rapidly growing as non-ICU monitoring is increasingly prioritized, bringing it to a projected $26.2B market size by 2022. “

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |